| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.093 | 0.09 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.073 | 0.09 |